Atlas Trials

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression

Clinical trial NCT01194856 · TERMINATED

Trial details

NCT number
NCT01194856
Sponsor
The Cleveland Clinic
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV InfectionMitochondrial Dysfunction
Start date
2010-10-01
Primary completion
2011-12-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.